|
|
Volumn 13, Issue 4, 2016, Pages 202-203
|
|
Immunotherapy: PD-1 says goodbye, TIM-3 says hello
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR;
PD 1 ANTIBODY;
PROGRAMMED DEATH 1 RECEPTOR;
REGULATOR PROTEIN;
TIM 3 ANTIBODY;
TIM 3 PROTEIN;
UNCLASSIFIED DRUG;
CANCER IMMUNOTHERAPY;
DRUG EFFICACY;
DRUG TREATMENT FAILURE;
EGFR GENE;
GENE MUTATION;
HUMAN;
KRAS GENE;
LUNG ADENOCARCINOMA;
LUNG CANCER;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
T LYMPHOCYTE;
TUMOR IMMUNITY;
TUMOR MICROENVIRONMENT;
UPREGULATION;
ADAPTIVE IMMUNITY;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
IMMUNOLOGY;
LUNG TUMOR;
MALE;
ADAPTIVE IMMUNITY;
ANIMALS;
HUMANS;
LUNG NEOPLASMS;
MALE;
PROGRAMMED CELL DEATH 1 RECEPTOR;
|
|
EID: 84961226039
PISSN: 17594774
EISSN: 17594782
Source Type: Journal
DOI: 10.1038/nrclinonc.2016.40 Document Type: Note |
|
Times cited : (61)
|
|
References (1)
|
